Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alumis Inc.

6.14
+0.50008.87%
Post-market: 6.00-0.1400-2.28%19:47 EDT
Volume:696.45K
Turnover:3.98M
Market Cap:334.06M
PE:-0.39
High:6.14
Open:5.65
Low:5.07
Close:5.64
Loading ...

Alumis Inc. Reports 2024 Results and Strategic Merger

TIPRANKS
·
27 Mar

Alumis Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
26 Mar

Sector Update: Health Care Stocks Decline Tuesday Afternoon

MT Newswires Live
·
26 Mar

BUZZ-Alumis jumps on licensing deal for skin drug

Reuters
·
25 Mar

Alumis Shares Rise on Licensing Agreement with Japanese Drug Company

Dow Jones
·
25 Mar

Alumis Shares up 26.5% After Licensing Agreement With Kaken Pharmaceutical

THOMSON REUTERS
·
25 Mar

Alumis Shares Jump 67.4% Premarket After Licensing Agreement With Kaken Pharmaceutical

THOMSON REUTERS
·
25 Mar

Alumis, Kaken Pharmaceutical Enter Collaboration, Licensing Deal for Dermatology Drug

MT Newswires Live
·
25 Mar

BRIEF-Alumis And Kaken Pharmaceutical Announce Collaboration And Licensing Agreement For ESK-001 In Dermatology In Japan

Reuters
·
25 Mar

Positive Buy Rating for Alumis Inc. Driven by Promising TYK2 Inhibitors and Strategic Advancements

TIPRANKS
·
25 Mar

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for Esk-001 in Dermatology in Japan

THOMSON REUTERS
·
25 Mar

Alumis Inc - to Receive $40 Million Upfront, Potential $140 Million in Milestone Payments

THOMSON REUTERS
·
25 Mar

Semtech Expands Anterix-Compatible Solutions for Utility Infrastructure

Business Wire
·
24 Mar

Oppenheimer Sticks to Their Buy Rating for Alumis Inc. (ALMS)

TIPRANKS
·
20 Mar

Alumis Price Target Cut to $15.00/Share From $19.00 by HC Wainwright & Co.

Dow Jones
·
20 Mar

Alumis Inc : H.c. Wainwright Cuts Target Price to $15 From $19

THOMSON REUTERS
·
20 Mar